Zacks Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-32,450
Closed -$8.82M 681
2015
Q3
$8.82M Sell
32,450
-25,722
-44% -$7.9M 0.31% 96
2015
Q2
$17.7M Buy
58,172
+331
+0.6% +$98.7K 0.56% 60
2015
Q1
$17.2M Sell
57,841
-5,046
-8% -$1.44M 0.54% 63
2014
Q4
$16.2M Buy
62,887
+1,366
+2% +$341K 0.52% 65
2014
Q3
$14.8M Sell
61,521
-2,929
-5% -$655K 0.52% 69
2014
Q2
$14.4M Sell
64,450
-6,488
-9% -$1.34M 0.51% 62
2014
Q1
$14.6M Buy
70,938
+739
+1% +$146K 0.54% 60
2013
Q4
$11.8M Buy
70,199
+26,814
+62% +$4.19M 0.47% 82
2013
Q3
$6.25M Sell
43,385
-37,921
-47% -$5.05M 0.27% 132
2013
Q2
$10.3M Buy
+81,306
New +$9.21M 0.47% 85

Other funds holding AGN

Zacks Investment Management's AGN Position: Q4 2015 in Review

Zacks Investment Management sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 32,450 shares — an estimated $8.82M sold.

Zacks Investment Management first reported a position in AGN in Q2 2013 and held it in 10 quarters. The position peaked at $17.7M in Q2 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Zacks Investment Management reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • Zacks Investment Management sold 32,450 Allergan plc shares in Q4 2015, an estimated $8.82M.
  • Zacks Investment Management first reported a position in Allergan plc in Q2 2013 and held it in 10 quarters.
  • Zacks Investment Management's Allergan plc position peaked at $17.7M in Q2 2015.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Zacks Investment Management's 13F filing for Q4 2015, filed 16 Feb 2016.